Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Advanced Health Intelligence in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.36.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in Advanced Health Intelligence. This rating has held steady since December 2022, when it changed from a Buy consensus rating.
Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It develops and patents BodyScan, a proprietary measurement/dimensioning technology that enables end-user to check and assess body dimensions using a smartphone. The company also provides FaceScan for measuring vital signs, and risks associated with cardiovascular disease, heart attack, and stroke; and DermaScan, a dermatological scanner. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as Advanced Human Imaging Limited and changed its name to Advanced Health Intelligence Ltd. in December 2022. Advanced Health Intelligence Ltd. was incorporated in 2014 and is based in South Perth, Australia.